This trial, supported by the Cancer Prevention Clinical Trials ... scope and results of clinical trials, including the anticipated Phase 3 study for amezalpat; anticipated therapeutic benefit ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of ... in the U.S. facing an uncertain future without approved treatment options,” said Chari A.

US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

“FDA approval of our forthcoming U.S. trials in patients with newly diagnosed pancreatic cancer and our investigator-initiated ... NH facility expected to complete its first phase of construction in ...

Clinical trial ... cancer using RNA therapeutics, today announced that the Safety Review Committee (SRC) monitoring its Phase I clinical trial has unanimously approved opening of the fourth cohort of ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

A recent study found that toxicity is routinely minimized in phase 3 oncology trials, especially those that are not industry ...